These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18675181)

  • 1. [Hepatitis C, cirrhosis and hepatocellular carcinoma].
    Zarski JP; Doffoel M; Filoche B; Marcellin P; Samuel D; Bedossa P
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S117-20. PubMed ID: 18675181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comments on case report: A 2.5 cm liver nodule discovered at ultrasound in a patient with controlled hepatitis C].
    Sitruk V; Seror O; Ziol M; Ganne-Carrié N; Trinchet JC
    Gastroenterol Clin Biol; 2002 Jan; 26(1):78-80. PubMed ID: 11938046
    [No Abstract]   [Full Text] [Related]  

  • 3. Different clinicopathological features of hepatitis B- and C-related hepatocellular carcinoma.
    Shiratori Y
    J Gastroenterol Hepatol; 1996 Oct; 11(10):942-3. PubMed ID: 8912131
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
    Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical screening and early treatment of hepatocellular carcinoma. Results of a French survey].
    Ganne-Carrié N; Chevret S; Barbare JC; Chaffaud C; Grando V; Vogt AM; Beaugrand M; Trinchet JC;
    Gastroenterol Clin Biol; 2002; 26(6-7):570-7. PubMed ID: 12193855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hepatocellular carcinoma after HBsAg clearance age before cirrhosis?: age before cirrhosis?
    Lutchman GA; Nguyen MA
    J Clin Gastroenterol; 2011 Jan; 45(1):4-5. PubMed ID: 21063212
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
    Henrion J; Libon E; De Maeght S; Deltenre P; Schapira M; Ghilain JM; Maisin JM; Heller FR
    Gastroenterol Clin Biol; 2003 May; 27(5):534-9. PubMed ID: 12843918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.
    Hirashima N; Mizokami M; Orito E; Koide T; Itazu I; Kumada K; Sakakibara K; Kano H; Lau JY
    J Gastroenterol Hepatol; 1996 Oct; 11(10):955-8. PubMed ID: 8912134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
    Azzaroli F; Colecchia A; Lodato F; Trerè D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G
    Aliment Pharmacol Ther; 2006 Jul; 24(1):129-36. PubMed ID: 16803611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
    Makino Y; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Fujikawa K; Takase K; Nakano T
    Anticancer Res; 2000; 20(5C):3709-15. PubMed ID: 11268443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual hyperplastic hepatocellular nodule in a patient with hepatitis C virus-related liver cirrhosis.
    Kageyama F; Kobayashi Y; Kawasaki T; Nakamura H; Baba S; Nakamura S; Nakashima O; Kojiro M
    Am J Gastroenterol; 1998 Dec; 93(12):2588-93. PubMed ID: 9860435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.